Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD ; volume:8 ; number:1 ; day:6 ; month:8 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.8.2018), 1-14, 12.2018
- Creator
-
Reid, Christopher A.
- Contributor
-
Nettesheim, Emily R.
Connor, Thomas B.
Lipinski, Daniel M.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-29726-7
- URN
-
urn:nbn:de:101:1-2018100221552137958494
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reid, Christopher A.
- Nettesheim, Emily R.
- Connor, Thomas B.
- Lipinski, Daniel M.
- SpringerLink (Online service)
Other Objects (12)
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF : 13 tables
“What should I inject next?” Challenging treatment decisions in the multiple anti-VEGF: a review of publications exploring anti-VEGF switching for nAMD
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF : 13 tables
“What should I inject next?” Challenging treatment decisions in the multiple anti-VEGF: a review of publications exploring anti-VEGF switching for nAMD
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF : 13 tables
“What should I inject next?” Challenging treatment decisions in the multiple anti-VEGF: a review of publications exploring anti-VEGF switching for nAMD
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
Book Review: Anti-VEGF Use in Ophthalmology
Future of anti-VEGF: biosimilars and biobetters
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD